Everyone should have the option of upgrading to better, damage resistant mitochondria, or the option to purchase effective maintenance of mitochondrial function

Everyone should have the option of upgrading to better, damage resistant mitochondria, or the option to purchase effective maintenance of mitochondrial function. Some haplotypes are objectively better than others, allowing greater athletic ability or resistance to age-related disease, but we can go beyond even just picking haplotype. Progressive damage to mitochondrial DNA is an important contribution to degenerative aging. Wholesale replacement of either mitochondria or mitochondrial DNA (via any one of four or five different approaches) is a very viable near term goal. All of the necessary component of such a treatment have been demonstrated in animals and human cells in the laboratory over the past decade, leaving just the painfully slow regulatory and development process.